Optomed has established a subsidiary in the USA

Optomed’s strategic plan is to expand its commercial activities in the US market, which was one of the reasons why the company raised funds through the IPO in December 2019. Establishing a subsidiary in the USA enables Optomed to create new business opportunities for its camera and software products, and support US customers better with a local presence.

Optomed’s CEO, Seppo Kopsala comments: ”Response from the US market has already been very good for our products within several years, and now it is time for us to start systematically investing more in this key market. This is an important step in our growth strategy. With our own subsidiary in the USA, we further improve our opportunities for continued growth in the world’s largest healthcare market.”

Optomed has a long history of selling its handheld fundus cameras in the US market via recognized and prominent OEM-customers Volk Optical Inc., Topcon Medical Systems Inc., Carl Zeiss Meditec Inc. and Haag-Streit. The OEM partnerships are very valuable to Optomed’s business and the company continues to provide full support to these partnerships also in the future while it also develops new business opportunities.

The USA is the world’s largest medical devices market and it covers over 40% of the global fundus camera market, where also Optomed operates in. Optomed’s handheld fundus cameras already have medical device approvals in the USA and Canada, so there are no barriers to expand our business in these markets.

 

Contact person

Seppo Kopsala
CEO, Optomed Plc
seppo.kopsala@optomed.com

 

Source: Optomed

← Back to news & blogs